+ Create post

Medtronic gains cardiac-software clearances across two ablation platforms

Medtronic ($MDT) obtained FDA clearance and a European CE mark for its latest Affera Prism-2 cardiac mapping software, alongside a CE mark for the PulseSelect ProxBox adapter and Proximity Indicator software. The Affera upgrade adds tools for comparing electrical signals and marking pacing locations, while supporting three-dimensional visualization of diagnostic catheters during procedures for abnormal heart rhythms. The PulseSelect addition provides real-time, impedance-based information about

0
0

Medtronic’s GI Genius system shows gains in large clinical-practice study

Cosmo reported new results for GI Genius, the AI-assisted endoscopy system it develops and Medtronic ($MDT) commercializes. The cluster-randomized quality-improvement study covered more than 334,000 colonoscopies across 139 US Veterans Health Administration facilities. Availability of the system was associated with 22% higher adjusted odds of detecting an adenoma. At facilities with access to the technology, the adenoma detection rate increased from 50.7% to 54.9%. The odds measure is not a 22-p

0
0

Medtronic wins FDA clearance for LigaSure instrument on Hugo robot

Medtronic ($MDT) received FDA clearance for the LigaSure RAS Maryland jaw instrument for its Hugo robotic-assisted surgery system. The instrument brings the company’s vessel-sealing technology to the robotic platform and is designed to seal vessels, tissue bundles and lymphatic structures up to seven millimeters using the Valleylab FT10 energy platform. The clearance expands the instrument set available for Hugo in its authorized US applications. Hugo’s US clearance currently covers urologic pro

0
0

Medtronic launches MiniMed share-exchange offer

Medtronic ($MDT) launched an exchange offer to split off at least 80.1% of MiniMed ($MMED), its former diabetes business. Investors can voluntarily exchange Medtronic shares for MiniMed stock at a 7% discount, subject to a cap of 4.5939 MiniMed shares for each accepted Medtronic share. Without that cap applying, the indicated value is approximately $107.53 of MiniMed stock for every $100 tendered. The final exchange ratio will depend on market prices near expiration, currently scheduled for Octo

0
0

Medtronic begins European clinical use of its Stealth AXiS surgical system

Medtronic ($MDT) announced the first European procedures using its Stealth AXiS surgical system, with more than 23 procedures performed across seven sites in Germany, the UK, Italy and Spain. The initial experience includes spinal surgery. The platform combines AI-driven planning, real-time navigation and robotic assistance within a single surgical workflow. Stealth AXiS forms part of Medtronic’s AiBLE ecosystem, which connects planning, procedural technologies and information across the surgica

0
0